|
J. Biol. Chem., Vol. 275, Issue 24, 17937-17945, June 16, 2000
Bone Morphogenetic Protein-9
AN AUTOCRINE/PARACRINE CYTOKINE IN THE LIVER*
Aaron F.
Miller,
Stephen A. K.
Harvey,
R. Scott
Thies , and
Merle
S.
Olson§
From the Department of Biochemistry, University of Texas Health
Science Center, San Antonio, Texas 78284-7600 and the
Genetics Institute, Inc.,
Cambridge, Massachusetts 02140
Bone morphogenetic proteins (BMPs) occupy
important roles during development serving to direct cells through
specific differentiation programs. While several BMPs are essential for
embryonic viability, their significance in mediating intercellular
communication in the context of adult organ systems remains largely
unknown. In the adult rat we characterized the tissue- and
cell-specific transcription and translation of BMP-9. Utilizing a
ribonuclease protection assay, we determined that in the adult animal,
BMP-9 expression occurs predominantly in the liver. Furthermore, we
determined that the non-parenchymal cells of the liver,
i.e. endothelial, Kupffer, and stellate cells, are the
major sources of this message. Western analyses corroborate the
ribonuclease protection assay results, confirming that LEC and KC
contain an abundance of immunoreactive BMP-9. Using
[125I]BMP-9, a receptor with specific binding affinity
for BMP-9 was characterized in primary cultures of hepatic endothelial
cells and Kupffer cells. BMP-9 binding to these cell types was observed to be fully reversible and highly specific for this ligand.
Additionally, we demonstrate that BMP-9 is specifically internalized
upon binding to its receptor. This may represent a novel BMP receptor
and is the first to be characterized in primary cultures of mature
liver non-parenchymal cells. Our results depict BMP-9 as a potential autocrine/paracrine mediator in the hepatic reticuloendothelial system.
*
This work was supported by National Institutes of Health
Grant DK-19473.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: University of Texas
Health Science Center at San Antonio, Dept. of Biochemistry, 7703 Floyd
Curl Dr., San Antonio, TX 78284-7760. E-mail: olson@ biochem.uthscsa.edu; Tel.: 210-567-3770; Fax: 210-567-6595.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Sharff, W.-X. Song, X. Luo, N. Tang, J. Luo, J. Chen, Y. Bi, B.-C. He, J. Huang, X. Li, et al.
Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells
J. Biol. Chem.,
January 2, 2009;
284(1):
649 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Caperuto, G. F. Anhe, T. D. Cambiaghi, E. H. Akamine, D. do Carmo Buonfiglio, J. Cipolla-Neto, R. Curi, and S. Bordin
Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance
Endocrinology,
December 1, 2008;
149(12):
6326 - 6335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ye, H. Kynaston, and W. G. Jiang
Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4
Mol. Cancer Res.,
October 1, 2008;
6(10):
1594 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. David, C. Mallet, M. Keramidas, N. Lamande, J.-M. Gasc, S. Dupuis-Girod, H. Plauchu, J.-J. Feige, and S. Bailly
Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor
Circ. Res.,
April 25, 2008;
102(8):
914 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lin, E. V. Valore, E. Nemeth, J. B. Goodnough, V. Gabayan, and T. Ganz
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4
Blood,
September 15, 2007;
110(6):
2182 - 2189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Scharpfenecker, M. van Dinther, Z. Liu, R.L. van Bezooijen, Q. Zhao, L. Pukac, C. W. G. M. Lowik, and P. ten Dijke
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis
J. Cell Sci.,
March 15, 2007;
120(6):
964 - 972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. David, C. Mallet, S. Mazerbourg, J.-J. Feige, and S. Bailly
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells
Blood,
March 1, 2007;
109(5):
1953 - 1961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Truksa, H. Peng, P. Lee, and E. Beutler
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6
PNAS,
July 5, 2006;
103(27):
10289 - 10293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Brown, Q. Zhao, K. A. Baker, C. Naik, C. Chen, L. Pukac, M. Singh, T. Tsareva, Y. Parice, A. Mahoney, et al.
Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors
J. Biol. Chem.,
July 1, 2005;
280(26):
25111 - 25118.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|